Skip to main content
. 2022 Apr 13;41(4):508–520. doi: 10.23876/j.krcp.21.193

Table 1.

Inclusion and exclusion criteria

Inclusion criteria Exclusion criteria
Inpatients and ER patients aged >18 years Arterial hypotension requiring inotropes or vasopressors (systolic blood pressure < 90 mmHg and mean arterial pressure < 70 mmHg)
Anuria or bilateral urinary outlet obstruction
Uncontrolled diabetes mellitus (HbA1C > 9%) or glucose of >500 mg/dL at baseline or uncontrolled diabetic ketoacidosis or uncontrolled hyperosmolar hyperglycemic syndrome
Decompensated LC: known LC with ascites or diuretics use or hepatic encephalopathy or varix
Severe hypernatremia: glucose-corrected serum sodiuma ≥ 155 mmol/L End-stage renal disease and receiving renal replacement therapy
Patients who are pregnant or breastfeeding
If the following features occur within 30 days prior to randomization
History of cardiac surgery excluding PCA, acute myocardial infarction, sustained ventricular tachycardia, ventricular fibrillation, acute coronary syndrome, and admission for heart failure
Uncontrolled increase of intracranial pressure
Written consent Subjects judged by investigators to have difficulty continuing the trial will also be excluded

ER, emergency room; HbA1c, glycosylated hemoglobin; LC, liver cirrhosis; PCA, percutaneous coronary angioplasty.

a

Glucose-corrected serum (Na+) = measured (Na+) + 2.4 × (glucose [mg/dL] – 100 [mg/dL])/100 mg/dL